Article
EU backs use of Novo Nordisk's weight loss drug in adolescents
Rating:
0.0
Views:
79
Likes:
1
Library:
1
The European Medicines Agency said on Friday its committee has recommended expanding the use of Danish drugmaker Novo Nordisk's weight loss drug in adolescents aged 12 years and older.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value